Insider Transactions Screener
Search for and identify insider purchases or sales of company shares. The screener offers additional information and analysis on the transactions and allows users to set up alerts and receive notifications when new transactions occur.
Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
---|---|---|---|---|---|---|
OCFC
|
Steven Scopellite
Director |
BUY
Grant, award, or other acquisition
|
Direct | 2,235 Added 28.16% |
-
|
Feb 28
2022 |
OCFC
|
Grace C Torres
Director |
BUY
Grant, award, or other acquisition
|
Direct | 2,235 Added 14.53% |
-
|
Feb 28
2022 |
OCFC
|
Patricia Lynne Turner
Director |
BUY
Grant, award, or other acquisition
|
Direct | 2,235 Added 33.01% |
-
|
Feb 28
2022 |
OCFC
|
John E Walsh
Director |
BUY
Grant, award, or other acquisition
|
Direct | 2,235 Added 4.78% |
-
|
Feb 28
2022 |
AVID
|
Kevin W. Riley
Chief Technology Officer & SVP |
SELL
Payment of exercise price or tax liability
|
Direct | 1,021 Reduced 2.93% |
$32,121
$31.46 p/Share
|
Feb 28
2022 |
CDNA
|
George Bickerstaff |
SELL
Open market or private sale
|
Direct | 25,000 Reduced 39.85% |
$977,750
$39.11 p/Share
|
Feb 28
2022 |
CDNA
|
Reginald Seeto
Director |
BUY
Grant, award, or other acquisition
|
Direct | 6,100 Added 3.01% |
-
|
Feb 28
2022 |
CDNA
|
Reginald Seeto
Director |
SELL
Payment of exercise price or tax liability
|
Direct | 2,947 Reduced 1.5% |
$113,106
$38.38 p/Share
|
Feb 28
2022 |
RXRX
|
Ramona Doyle
Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 15,625 Added 12.16% |
$38,750
$2.48 p/Share
|
Feb 28
2022 |
MYGN
|
Jayne B. Hart
Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 10,500 Added 5.84% |
$251,790
$23.98 p/Share
|
Feb 28
2022 |
MYGN
|
Jayne B. Hart
Officer |
SELL
Open market or private sale
|
Direct | 10,500 Reduced 5.95% |
$262,500
$25.0 p/Share
|
Feb 28
2022 |
LGND
|
John W Kozarich
Director |
BUY
Exercise of conversion of derivative security
|
Direct | 7,335 Added 14.83% |
$91,908
$12.53 p/Share
|
Feb 28
2022 |
LGND
|
John W Kozarich
Director |
SELL
Open market or private sale
|
Direct | 908 Reduced 2.16% |
$93,179
$102.62 p/Share
|
Feb 28
2022 |
XMTR
|
James M Rallo
Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 23,529 Added 50.0% |
$85,881
$3.65 p/Share
|
Feb 28
2022 |
XMTR
|
James M Rallo
Chief Financial Officer |
SELL
Open market or private sale
|
Direct | 23,529 Reduced 100.0% |
$1,130,333
$48.04 p/Share
|
Feb 28
2022 |
POLY
|
Carl Wiese
Top Sales Executive - Global.E |
SELL
Payment of exercise price or tax liability
|
Direct | 9,305 Reduced 10.42% |
$262,122
$28.17 p/Share
|
Feb 28
2022 |
HOPE
|
Thomas Stenger
SEVP, Chief Risk Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 395 Reduced 1.76% |
$6,699
$16.96 p/Share
|
Feb 28
2022 |
STRA
|
Robert S Silberman
CHAIRMAN |
BUY
Open market or private purchase
|
Direct | 13,001 Added 5.17% |
$787,341
$60.56 p/Share
|
Feb 28
2022 |
DRH
|
Briony R. Quinn
EVP & Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 5,849 Reduced 2.76% |
$55,858
$9.55 p/Share
|
Feb 28
2022 |
DRH
|
Troy Furbay
EVP & Chief Investment Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 5,314 Reduced 0.99% |
$50,749
$9.55 p/Share
|
Feb 28
2022 |
DRH
|
Troy Furbay
EVP & Chief Investment Officer |
BUY
Grant, award, or other acquisition
|
Direct | 47,844 Added 8.21% |
-
|
Feb 28
2022 |
DRH
|
Thomas G. Healy
EVP & Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct | 43,744 Added 8.74% |
-
|
Feb 28
2022 |
DRH
|
Mark W Brugger
President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct | 50,900 Reduced 2.06% |
$486,095
$9.55 p/Share
|
Feb 28
2022 |
DRH
|
Mark W Brugger
President and CEO |
BUY
Grant, award, or other acquisition
|
Direct | 158,571 Added 6.03% |
-
|
Feb 28
2022 |
DRH
|
William J Tennis
EVP & General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct | 3,838 Reduced 0.87% |
$36,653
$9.55 p/Share
|
Feb 28
2022 |
DRH
|
William J Tennis
EVP & General Counsel |
BUY
Grant, award, or other acquisition
|
Direct | 34,448 Added 7.25% |
-
|
Feb 28
2022 |
DRH
|
Jeffrey Donnelly
Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 5,609 Reduced 1.78% |
$53,566
$9.55 p/Share
|
Feb 28
2022 |
AAWW
|
Michael Steen
EVP & CMO |
SELL
Payment of exercise price or tax liability
|
Direct | 13,274 Reduced 11.92% |
$1,040,151
$78.36 p/Share
|
Feb 28
2022 |
AAWW
|
Michael Steen
EVP & CMO |
BUY
Grant, award, or other acquisition
|
Direct | 33,731 Added 25.03% |
-
|
Feb 28
2022 |
AAWW
|
Spencer Schwartz
EVP & CFO |
SELL
Payment of exercise price or tax liability
|
Direct | 13,834 Reduced 26.11% |
$1,084,032
$78.36 p/Share
|
Feb 28
2022 |
AAWW
|
Spencer Schwartz
EVP & CFO |
BUY
Grant, award, or other acquisition
|
Direct | 29,852 Added 41.44% |
-
|
Feb 28
2022 |
AAWW
|
Keith H. Mayer
SVP & Controller |
SELL
Payment of exercise price or tax liability
|
Direct | 1,067 Reduced 10.18% |
$83,610
$78.36 p/Share
|
Feb 28
2022 |
AAWW
|
Keith H. Mayer
SVP & Controller |
BUY
Grant, award, or other acquisition
|
Direct | 2,958 Added 23.65% |
-
|
Feb 28
2022 |
AAWW
|
Adam Richard Kokas
EVP, GC & Secty. |
SELL
Payment of exercise price or tax liability
|
Direct | 15,240 Reduced 26.02% |
$1,194,206
$78.36 p/Share
|
Feb 28
2022 |
AAWW
|
Adam Richard Kokas
EVP, GC & Secty. |
BUY
Grant, award, or other acquisition
|
Direct | 29,852 Added 39.01% |
-
|
Feb 28
2022 |
AAWW
|
James Anthony Forbes
EVP & COO |
SELL
Payment of exercise price or tax liability
|
Direct | 1,538 Reduced 13.74% |
$120,518
$78.36 p/Share
|
Feb 28
2022 |
AAWW
|
James Anthony Forbes
EVP & COO |
BUY
Grant, award, or other acquisition
|
Direct | 4,242 Added 30.13% |
-
|
Feb 28
2022 |
AAWW
|
John W Dietrich
President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct | 13,274 Reduced 11.28% |
$1,040,151
$78.36 p/Share
|
Feb 28
2022 |
AAWW
|
John W Dietrich
President & CEO |
BUY
Grant, award, or other acquisition
|
Direct | 33,731 Added 23.91% |
-
|
Feb 28
2022 |
OPK
|
Phillip Md Et Al Frost
CEO & Chairman |
BUY
Open market or private purchase
|
Indirect | 100,000 Added 0.01% |
$310,000
$3.1 p/Share
|
Feb 28
2022 |
RLJ
|
Leslie D. Hale
President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct | 23,287 Reduced 1.69% |
$334,634
$14.37 p/Share
|
Feb 28
2022 |
RLJ
|
Sean M Mahoney
EVP and CFO |
SELL
Payment of exercise price or tax liability
|
Direct | 3,988 Reduced 1.19% |
$57,308
$14.37 p/Share
|
Feb 28
2022 |
RLJ
|
Robert L Johnson
Executive Chairman |
SELL
Payment of exercise price or tax liability
|
Direct | 6,399 Reduced 0.49% |
$91,954
$14.37 p/Share
|
Feb 28
2022 |
RLJ
|
Christopher Andrew Gormsen
Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 1,140 Reduced 0.86% |
$16,382
$14.37 p/Share
|
Feb 28
2022 |
ITRI
|
Michel Cadieux
SVP, HR |
SELL
Open market or private sale
|
Direct | 1,745 Reduced 7.46% |
$86,378
$49.5 p/Share
|
Feb 28
2022 |
CALX
|
John Matthew Collins
Chief Commercial Ops Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 5,000 Added 50.0% |
$34,750
$6.95 p/Share
|
Feb 28
2022 |
CALX
|
John Matthew Collins
Chief Commercial Ops Officer |
SELL
Open market or private sale
|
Direct | 5,000 Reduced 100.0% |
$269,300
$53.86 p/Share
|
Feb 28
2022 |
PSMT
|
Philanthropies Foundation Price |
SELL
Open market or private sale
|
Direct | 10,000 Reduced 0.29% |
$729,500
$72.95 p/Share
|
Feb 28
2022 |
PSMT
|
Robert E Price |
SELL
Open market or private sale
|
Indirect | 10,000 Reduced 0.27% |
$729,500
$72.95 p/Share
|
Feb 28
2022 |
TRUP
|
Andrew D. Wolff
Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 77 Reduced 10.19% |
$6,902
$89.63 p/Share
|
Feb 28
2022 |